Key result
Isolation of human ventricular cardiomyocytes using vibratome-cut myocardial slices yielded significantly more viable cells than the tissue-chunk method (45.0 vs. 6.87 cells/mg, p < 0.05).
Why the study?
Isolating human cardiomyocytes is challenging because human specimens typically do not allow coronary perfusion, and alternative protocols yield few viable cells from rare tissue samples.
A novel vibratome-based protocol enables efficient isolation of viable ventricular cardiomyocytes from minimal amounts of human and animal myocardial tissue, even after up to 36 hours of cold storage.
Answers are grounded in this paper and cite their sources.
Protocol yields viable human cardiomyocytes from small specimens; leaves open whether it supports routine high-throughput research use.
The isolation of ventricular cardiac myocytes from animal and human hearts is a fundamental method in cardiac research. Animal cardiomyocytes are commonly isolated by coronary perfusion with digestive enzymes. However, isolating human cardiomyocytes is challenging because human myocardial specimens usually do not allow for coronary perfusion, and alternative isolation protocols result in poor yields of viable cells. In addition, human myocardial specimens are rare and only regularly available at institutions with on-site cardiac surgery. This hampers the translation of findings from animal to human cardiomyocytes. Described here is a reliable protocol that enables efficient isolation of ventricular myocytes from human and animal myocardium. To increase the surface-to-volume ratio while minimizing cell damage, myocardial tissue slices 300 µm thick are generated from myocardial specimens with a vibratome. Tissue slices are then digested with protease and collagenase. Rat myocardium was used to establish the protocol and quantify yields of viable, calcium-tolerant myocytes by flow-cytometric cell counting. Comparison with the commonly used tissue-chunk method showed significantly higher yields of rod-shaped cardiomyocytes (41.5 ± 11.9 vs. 7.89 ± 3.6%, p < 0.05). The protocol was translated to failing and non-failing human myocardium, where yields were similar as in rat myocardium and, again, markedly higher than with the tissue-chunk method (45.0 ± 15.0 vs. 6.87 ± 5.23 cells/mg, p < 0.05). Notably, with the protocol presented it is possible to isolate reasonable numbers of viable human cardiomyocytes (9-200 cells/mg) from minimal amounts of tissue (<50 mg). Thus, the method is applicable to healthy and failing myocardium from both human and animal hearts. Furthermore, it is possible to isolate excitable and contractile myocytes from human tissue specimens stored for up to 36 h in cold cardioplegic solution, rendering the method particularly useful for laboratories at institutions without on-site cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Fiegle et al. (2020) studied Healthy and failing myocardium. Vibratome-cut myocardial slices protocol vs. Tissue-chunk method was evaluated on Yield of viable cardiomyocytes from human myocardium (cells/mg) (p=< 0.05). Isolation of human ventricular cardiomyocytes using vibratome-cut myocardial slices yielded significantly more viable cells than the tissue-chunk method (45.0 vs. 6.87 cells/mg, p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: